Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipoprotein(a): Knowns, unknowns and uncertainties
Massimiliano Ruscica, Cesare R. Sirtori, Alberto Corsini, et al.
Pharmacological Research (2021) Vol. 173, pp. 105812-105812
Closed Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment
Stamatios Lampsas, Maria Xenou, Evangelos Oikonomou, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 969-969
Open Access | Times Cited: 69
Triglyceride-glucose index: carotid intima-media thickness and cardiovascular risk in a European population
Chiara Pavanello, Massimiliano Ruscica, Sofia Castiglione, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood
Olli T. Raitakari, Noora Kartiosuo, Katja Pahkala, et al.
Circulation (2022) Vol. 147, Iss. 1, pp. 23-31
Closed Access | Times Cited: 53
Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review
Nicola Ferri, Massimiliano Ruscica, Sergio Fazio, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 943-943
Open Access | Times Cited: 15
Lipoprotein(a) and Cardiovascular Disease in Chinese Population
Jian‐Jun Li, Changsheng Ma, Dong Zhao, et al.
JACC Asia (2022) Vol. 2, Iss. 6, pp. 653-665
Open Access | Times Cited: 37
Hypercholesterolemia and inflammation—Cooperative cardiovascular risk factors
Antonio Gallo, Wilfried Le Goff, Raul D. Santos, et al.
European Journal of Clinical Investigation (2024)
Open Access | Times Cited: 7
Association between Lipoprotein(a) and premature atherosclerotic cardiovascular disease: a systematic review and meta-analysis
Xu Tian, Nan Zhang, Gary Tse, et al.
European Heart Journal Open (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 6
Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Marica Meroni, Miriam Longo, Rosa Lombardi, et al.
Hepatology Communications (2021) Vol. 6, Iss. 3, pp. 535-549
Open Access | Times Cited: 36
The Role of High-Density Lipoprotein Cholesterol in 2022
Cesare R. Sirtori, Alberto Corsini, Massimiliano Ruscica
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 5, pp. 365-377
Open Access | Times Cited: 25
Omega-3 and cardiovascular prevention – Is this still a choice?
Massimiliano Ruscica, Cesare R. Sirtori, Stefano Carugo, et al.
Pharmacological Research (2022) Vol. 182, pp. 106342-106342
Open Access | Times Cited: 23
Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor
Marlys L. Koschinsky, Erik S.G. Stroes, Florian Kronenberg
Pharmacological Research (2023) Vol. 194, pp. 106843-106843
Open Access | Times Cited: 14
The ins and outs of lipoprotein(a) assay methods
Maryam Heydari, Majid Rezayi, Massimiliano Ruscica, et al.
Archives of Medical Science - Atherosclerotic Diseases (2024) Vol. 8, Iss. 1, pp. 128-139
Open Access | Times Cited: 5
Predictive value of lipoprotein(a) for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA2DS2-VASc scores: a cross-sectional study
Kamila Kamili, Tingting Zheng, Chaodi Luo, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?
Georgios Tsioulos, Dimitris Kounatidis, Natalia G. Vallianou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3537-3537
Open Access | Times Cited: 5
PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical Guidance
Xiaoming Jia, Mahmoud Al Rifai, Anum Saeed, et al.
Vascular Health and Risk Management (2022) Vol. Volume 18, pp. 555-566
Open Access | Times Cited: 20
Updates in Small Interfering RNA for the Treatment of Dyslipidemias
Stefano Carugo, Cesare R. Sirtori, Guido Gelpi, et al.
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 11, pp. 805-817
Open Access | Times Cited: 12
Development of a fully automated latex-enhanced immunoturbidimetric method for quantitative serum Lp(a) measurement
Yanyan Liu, Meijiao Li, Hao Zhang, et al.
Biotechnology Letters (2025) Vol. 47, Iss. 2
Closed Access
Cross-sectional study of lipoprotein(a) and the severity of coronary artery disease, cerebrovascular disease, and peripheral vascular disease in a group of South Asian patients
P. M. Athauda arachchi, Lalindra Kaththiriarachchi, Wilson Salgado, et al.
Cardiovascular Endocrinology & Metabolism (2025) Vol. 14, Iss. 2
Open Access
RNA-based therapy in the management of lipid disorders: a review
Dirk Blom, A. David Marais, Rajen Moodley, et al.
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Lipoprotein (a) concentration as a risk factor for ischaemic stroke and its subtypes
Antónia Lacková, Zuzana Gdovinová, Miriam Kozárová, et al.
Neurologia i Neurochirurgia Polska (2024) Vol. 58, Iss. 3, pp. 316-322
Open Access | Times Cited: 3
Fundamentals of lipoprotein(a) request and quantification in the clinical laboratory
Teresa Arrobas Velilla, Carla Fernández Prendes, Núria Amigó, et al.
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio (2025) Vol. 6, Iss. 1, pp. 7-16
Open Access
Aspectos fundamentales en la solicitud y determinación de la lipoproteína(a) en el laboratorio clínico
Teresa Arrobas Velilla, Carla Fernández Prendes, Núria Amigó, et al.
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio (2025) Vol. 6, Iss. 1, pp. 17-27
Open Access
Comprehensive evaluation of siRNA therapeutics on Lp(a): A network meta‐analysis
Song Liu, Xingjin Wang, Jiaqiang Hu, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Lipoprotein(a) levels and cardiovascular mortality risk in Chinese patients undergoing hemodialysis
Qiaojing Liang, Guojuan Zhang, Liping Jiang, et al.
International Urology and Nephrology (2025)
Closed Access
Plasma Homocysteine Level Is Independently Associated With Conventional Atherogenic Lipid Profile and Remnant Cholesterol in Adults
Liyuan Zhou, Jia Liu, Yu An, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top